{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:46:26Z","timestamp":1790401586715,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T00:00:00Z","timestamp":1487548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T00:00:00Z","timestamp":1487548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R03-DA037770"],"award-info":[{"award-number":["R03-DA037770"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12954-017-0139-0","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T12:50:52Z","timestamp":1487595052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Willingness to use a supervised injection facility among young adults who use prescription opioids non-medically: a cross-sectional study"],"prefix":"10.1186","volume":"14","author":[{"given":"Benjamin A.","family":"Bouvier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Elston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Hadland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci C.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon D. L.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,20]]},"reference":[{"key":"139_CR1","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","volume":"372","author":"BM Mathers","year":"2008","unstructured":"Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA, Wodak A, Panda S, Tyndall M, Toufik A, Mattick RP. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372:1733\u201345.","journal-title":"Lancet"},{"key":"139_CR2","doi-asserted-by":"publisher","first-page":"62s","DOI":"10.1002\/hep.510260711","volume":"26","author":"MJ Alter","year":"1997","unstructured":"Alter MJ. Epidemiology of hepatitis C. Hepatology. 1997;26:62s\u20135s.","journal-title":"Hepatology"},{"key":"139_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/10550887.2015.1127712","volume":"35","author":"S Lake","year":"2016","unstructured":"Lake S, Kennedy MC. Health outcomes associated with illicit prescription opioid injection: a systematic review. J Addict Dis. 2016;35:73\u201391.","journal-title":"J Addict Dis"},{"key":"139_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.drugalcdep.2006.10.006","volume":"88","author":"SG Sherman","year":"2007","unstructured":"Sherman SG, Cheng Y, Kral AH. Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. city. Drug Alcohol Depend. 2007;88:182\u20137.","journal-title":"Drug Alcohol Depend"},{"key":"139_CR5","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1086\/313703","volume":"30","author":"IA Binswanger","year":"2000","unstructured":"Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000;30:579\u201381.","journal-title":"Clin Infect Dis"},{"key":"139_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.drugalcdep.2008.12.002","volume":"101","author":"AM Salmon","year":"2009","unstructured":"Salmon AM, Dwyer R, Jauncey M, van Beek I, Topp L, Maher L. Injecting-related injury and disease among clients of a supervised injecting facility. Drug Alcohol Depend. 2009;101:132\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"139_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1093\/jurban\/jtg050","volume":"80","author":"D Buchanan","year":"2003","unstructured":"Buchanan D, Shaw S, Teng W, Hiser P, Singer M. Neighborhood differences in patterns of syringe access, use, and discard among injection drug users: implications for HIV outreach and prevention education. J Urban Health. 2003;80:438\u201354.","journal-title":"J Urban Health"},{"key":"139_CR8","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/002204260203200113","volume":"32","author":"RS Broadhead","year":"2002","unstructured":"Broadhead RS, Kerr TH, Grund J-PC, Altice FL. Safer injection facilities in North America: their place in public policy and health initiatives. J Drug Issues. 2002;32:329\u201355.","journal-title":"J Drug Issues"},{"key":"139_CR9","unstructured":"Hedrich D, Kerr T, Dubois-Arber F. Drug consumption facilities in Europe and beyond. Harm reduction: evidence, impacts and challenges. European Monitoring Centre for Drugs and Drug Addiction; 2010. \n                    http:\/\/www.emcdda.europa.eu\/publications\/monographs\/harm-reduction\n                    \n                  . Accessed 29 Oct 2016."},{"key":"139_CR10","unstructured":"EMCDDA. Drug consumption rooms: an overview of provision and evidence. Perspectives on Drugs. European Monitoring Centre for Drugs and Drug Addiction; 2016. \n                    http:\/\/www.emcdda.europa.eu\/topics\/pods\/drug-consumption-rooms\n                    \n                  . Accessed 29 Oct 2016."},{"key":"139_CR11","doi-asserted-by":"crossref","unstructured":"Kimber J, Dolan K, Wodak A. Survey of drug consumption rooms: service delivery and perceived public health and amenity impact. Drug Alcohol Rev. 2005, 24:21-24.","DOI":"10.1080\/09595230500125047"},{"key":"139_CR12","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/j.1465-3362.2009.00025.x","volume":"28","author":"W Small","year":"2009","unstructured":"Small W, Van Borek N, Fairbairn N, Wood E, Kerr T. Access to health and social services for IDU: the impact of a medically supervised injection facility. Drug Alcohol Rev. 2009;28:341\u20136.","journal-title":"Drug Alcohol Rev"},{"key":"139_CR13","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","volume":"377","author":"BD Marshall","year":"2011","unstructured":"Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377:1429\u201337.","journal-title":"Lancet"},{"key":"139_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0140-6736(05)66475-6","volume":"366","author":"T Kerr","year":"2005","unstructured":"Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005;366:316\u20138.","journal-title":"Lancet"},{"key":"139_CR15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1477-7517-5-32","volume":"5","author":"D Fast","year":"2008","unstructured":"Fast D, Small W, Wood E, Kerr T. The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility. Harm Reduct J. 2008;5:32.","journal-title":"Harm Reduct J"},{"key":"139_CR16","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.addbeh.2006.07.013","volume":"32","author":"S Petrar","year":"2007","unstructured":"Petrar S, Kerr T, Tyndall MW, Zhang R, Montaner JS, Wood E. Injection drug users\u2019 perceptions regarding use of a medically supervised safer injecting facility. Addict Behav. 2007;32:1088\u201393.","journal-title":"Addict Behav"},{"key":"139_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1503\/cmaj.1040774","volume":"171","author":"E Wood","year":"2004","unstructured":"Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, Tyndall MW. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. CMAJ. 2004;171:731\u20134.","journal-title":"CMAJ"},{"key":"139_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1111\/j.1360-0443.2009.02837.x","volume":"105","author":"AM Salmon","year":"2010","unstructured":"Salmon AM, van Beek I, Amin J, Kaldor J, Maher L. The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia. Addiction. 2010;105:676\u201383.","journal-title":"Addiction"},{"key":"139_CR19","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1111\/j.1360-0443.2007.01818.x","volume":"102","author":"E Wood","year":"2007","unstructured":"Wood E, Tyndall MW, Zhang R, Montaner JS, Kerr T. Rate of detoxification service use and its impact among a cohort of supervised injecting facility users. Addiction. 2007;102:916\u20139.","journal-title":"Addiction"},{"key":"139_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.drugalcdep.2005.11.011","volume":"83","author":"MW Tyndall","year":"2006","unstructured":"Tyndall MW, Kerr T, Zhang R, King E, Montaner JG, Wood E. Attendance, drug use patterns, and referrals made from North America\u2019s first supervised injection facility. Drug Alcohol Depend. 2006;83:193\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"139_CR21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.drugpo.2009.03.004","volume":"21","author":"MA Andresen","year":"2010","unstructured":"Andresen MA, Boyd N. A cost-benefit and cost-effectiveness analysis of Vancouver\u2019s supervised injection facility. Int J Drug Policy. 2010;21:70\u20136.","journal-title":"Int J Drug Policy"},{"key":"139_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1747-597X-8-25","volume":"8","author":"E Jozaghi","year":"2013","unstructured":"Jozaghi E, Reid AA, Andresen MA. A cost-benefit\/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, Canada. Subst Abuse Treat Prev Policy. 2013;8:25.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"139_CR23","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1503\/cmaj.080808","volume":"179","author":"AM Bayoumi","year":"2008","unstructured":"Bayoumi AM, Zaric GS. The cost-effectiveness of Vancouver\u2019s supervised injection facility. CMAJ. 2008;179:1143\u201351.","journal-title":"CMAJ"},{"key":"139_CR24","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/add.13195","volume":"111","author":"EA Enns","year":"2016","unstructured":"Enns EA, Zaric GS, Strike CJ, Jairam JA, Kolla G, Bayoumi AM. Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada. Addiction. 2016;111:475\u201389.","journal-title":"Addiction"},{"key":"139_CR25","first-page":"1","volume":"0","author":"A Irwin","year":"2016","unstructured":"Irwin A, Jozaghi E, Bluthenthal RN, Kral AH. A cost-benefit analysis of a potential supervised injection facility in San Francisco, California, USA. J Drug Issues. 2016;0:1\u201321.","journal-title":"J Drug Issues"},{"key":"139_CR26","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","volume":"64","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths\u2014United States, 2000\u20132014. MMWR Morb Mortal Wkly Rep. 2016;64:1378\u201382.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"139_CR27","first-page":"443","volume":"64","author":"C Conrad","year":"2015","unstructured":"Conrad C, Bradley HM, Broz D, Buddha S, Chapman EL, Galang RR, Hillman D, Hon J, Hoover KW, Patel MR, Perez A, Peters PJ, Pontones P, Roseberry JC, Sandoval M, Shields J, Walthall J, Waterhouse D, Weidle PJ, Wu H, Duwve JM. Community outbreak of HIV infection linked to injection drug use of oxymorphone\u2014Indiana, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:443\u20134.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"139_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","volume":"145","author":"C Potier","year":"2014","unstructured":"Potier C, Laprevote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend. 2014;145:48\u201368.","journal-title":"Drug Alcohol Depend"},{"key":"139_CR29","volume-title":"21 USCA \u00a7 856. Title 21 United States Code Controlled Substances Act","author":"USCA","year":"2003","unstructured":"USCA. 21 USCA \u00a7 856. Title 21 United States Code Controlled Substances Act. 2003."},{"key":"139_CR30","first-page":"29","volume":"97","author":"TC Green","year":"2014","unstructured":"Green TC, Bratberg J, Dauria EF, Rich JD. Responding to opioid overdose in Rhode Island: where the medical community has gone and where we need to go. R I Med J (2013). 2014;97:29\u201333.","journal-title":"R I Med J (2013)"},{"key":"139_CR31","first-page":"531","volume":"63","author":"MC Mercado-Crespo","year":"2014","unstructured":"Mercado-Crespo MC, Sumner SA, Spelke MB, Sugerman DE, Stanley C. Notes from the field: increase in fentanyl-related overdose deaths\u2014Rhode Island, November 2013\u2013March 2014. MMWR Morb Mortal Wkly Rep. 2014;63:531.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"139_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s13181-015-0477-9","volume":"11","author":"MJ Lozier","year":"2015","unstructured":"Lozier MJ, Boyd M, Stanley C, Ogilvie L, King E, Martin C, Lewis L. Acetyl fentanyl, a novel fentanyl analog, causes 14 overdose deaths in Rhode Island, March\u2013May 2013. J Med Toxicol. 2015;11:208\u201317.","journal-title":"J Med Toxicol"},{"key":"139_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","volume":"171","author":"J Suzuki","year":"2016","unstructured":"Suzuki J, El-Haddad S. A review: fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend. 2016;171:107\u201316.","journal-title":"Drug Alcohol Depend"},{"key":"139_CR34","unstructured":"RIDOH. RIDOH monthly overdose death data show spikes in fentanyl-related deaths and illicit drug overdose deaths. Rhode Island Department of Health; 2016. \n                    http:\/\/www.ri.gov\/press\/view\/27491\n                    \n                  . Accessed 29 Oct 2016."},{"key":"139_CR35","first-page":"34","volume":"97","author":"S Bowman","year":"2014","unstructured":"Bowman S, Engelman A, Koziol J, Mahoney L, Maxwell C, McKenzie M. The Rhode Island community responds to opioid overdose deaths. R I Med J (2013). 2014;97:34\u20137.","journal-title":"R I Med J (2013)"},{"key":"139_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/wmh3.123","volume":"6","author":"KA Neill","year":"2014","unstructured":"Neill KA. Tough on drugs: law and order dominance and the neglect of public health in U.S. drug policy. World Med Health Policy. 2014;6:375\u201394.","journal-title":"World Med Health Policy"},{"key":"139_CR37","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1467-842X.1999.tb01306.x","volume":"23","author":"C Fry","year":"1999","unstructured":"Fry C, Fox S, Rumbold G. Establishing safe injecting rooms in Australia: attitudes of injecting drug users. Aust N Z J Public Health. 1999;23:501\u20134.","journal-title":"Aust N Z J Public Health"},{"key":"139_CR38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF03405777","volume":"95","author":"TC Green","year":"2004","unstructured":"Green TC, Hankins CA, Palmer D, Boivin JF, Platt R. My place, your place, or a safer place: the intention among Montreal injecting drug users to use supervised injecting facilities. Can J Public Health. 2004;95:110\u20134.","journal-title":"Can J Public Health"},{"key":"139_CR39","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12954-015-0083-9","volume":"12","author":"A Shaw","year":"2015","unstructured":"Shaw A, Lazarus L, Pantalone T, LeBlanc S, Lin D, Stanley D, Chepesiuk C, Patel S, Tyndall M. Risk environments facing potential users of a supervised injection site in Ottawa, Canada. Harm Reduct J. 2015;12:49.","journal-title":"Harm Reduct J"},{"key":"139_CR40","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/00126334-200301010-00002","volume":"32","author":"E Wood","year":"2003","unstructured":"Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW, Hogg RS, O'Shaughnessy MV, Schechter MT. The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users. J Acquir Immune Defic Syndr. 2003;32:2\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"139_CR41","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.drugalcdep.2010.02.009","volume":"110","author":"AH Kral","year":"2010","unstructured":"Kral AH, Wenger L, Carpenter L, Wood E, Kerr T, Bourgois P. Acceptability of a safer injection facility among injection drug users in San Francisco. Drug Alcohol Depend. 2010;110:160\u20133.","journal-title":"Drug Alcohol Depend"},{"key":"139_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.drugpo.2006.11.018","volume":"18","author":"N Hunt","year":"2007","unstructured":"Hunt N, Lloyd C, Kimber J, Tompkins C. Public injecting and willingness to use a drug consumption room among needle exchange programme attendees in the UK. Int J Drug Policy. 2007;18:62\u20135.","journal-title":"Int J Drug Policy"},{"key":"139_CR43","first-page":"1","volume":"169","author":"T Kerr","year":"2003","unstructured":"Kerr T, Wood E, Small D, Palepu A, Tyndall MW. Potential use of safer injecting facilities among injection drug users in Vancouver\u2019s Downtown Eastside. Can Med Assoc J. 2003;169:1\u20135.","journal-title":"Can Med Assoc J"},{"key":"139_CR44","unstructured":"Fischer B, Allard C. Feasibility study on \u2018Supervised Drug Consumption\u2019 options in the City of Victoria. Vancouver Island Health Authority; 2007. \n                    http:\/\/www.viha.ca\/NR\/rdonlyres\/9C3846B7-4836-4F1C-8CE2-952273E3A439\/0\/carbc_feasibility_study.pdf\n                    \n                  . Accessed 29 Oct 2016."},{"key":"139_CR45","unstructured":"Bayoumi AM, Strike C, Brandeau M, Degani N, Fischer B, Glazier R, Hopkins S, Leonard L, Luce J, Millson P, et al. Report of the Toronto and Ottawa Supervised Consumption Assessment Study. Canadian AIDS Treatment Information Exchange; 2012. \n                    http:\/\/www.catie.ca\/sites\/default\/files\/TOSCA%20report%202012.pdf\n                    \n                  . Accessed 29 Oct 2016."},{"key":"139_CR46","volume-title":"Needs Assessment for a Safer Injecting Facility in Ottawa, Canada","author":"L Leonard","year":"2008","unstructured":"Leonard L, DeRubeis E, Strike C. Needs Assessment for a Safer Injecting Facility in Ottawa, Canada. 2008. \n                    http:\/\/citeseerx.ist.psu.edu\/viewdoc\/download?doi=10.1.1.555.2958&rep=rep1&type=pdf\n                    \n                  . Accessed 29 Oct 2016."},{"key":"139_CR47","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0955-3959(02)00076-2","volume":"13","author":"CL Fry","year":"2002","unstructured":"Fry CL. Injecting drug user attitudes towards rules for supervised injecting rooms: implications for uptake. Int J Drug Policy. 2002;13:471\u20136.","journal-title":"Int J Drug Policy"},{"key":"139_CR48","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jadohealth.2014.04.013","volume":"55","author":"SE Hadland","year":"2014","unstructured":"Hadland SE, DeBeck K, Kerr T, Nguyen P, Simo A, Montaner JS, Wood E. Use of a medically supervised injection facility among street youth. J Adolesc Health. 2014;55:684\u20139.","journal-title":"J Adolesc Health"},{"key":"139_CR49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.socscimed.2014.01.051","volume":"106","author":"R McNeil","year":"2014","unstructured":"McNeil R, Small W. \u2018Safer environment interventions\u2019: a qualitative synthesis of the experiences and perceptions of people who inject drugs. Soc Sci Med. 2014;106:151\u20138.","journal-title":"Soc Sci Med"},{"key":"139_CR50","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.amepre.2005.04.011","volume":"29","author":"E Wood","year":"2005","unstructured":"Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, Kerr T. Do supervised injecting facilities attract higher-risk injection drug users? Am J Prev Med. 2005;29:126\u201330.","journal-title":"Am J Prev Med"},{"key":"139_CR51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMra1508490","volume":"374","author":"WM Compton","year":"2016","unstructured":"Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. New Engl J Med. 2016;374:154\u201363.","journal-title":"New Engl J Med"},{"key":"139_CR52","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/01.qai.0000186391.49205.3b","volume":"41","author":"A Neaigus","year":"2006","unstructured":"Neaigus A, Gyarmathy VA, Miller M, Frajzyngier VM, Friedman SR, Des Jarlais DC. Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr. 2006;41:493\u2013503.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"139_CR53","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.drugpo.2012.09.003","volume":"24","author":"TM Watson","year":"2013","unstructured":"Watson TM, Strike C, Kolla G, Penn R, Jairam J, Hopkins S, Luce J, Degani N, Millson P, Bayoumi AM. Design considerations for supervised consumption facilities (SCFs): preferences for facilities where people can inject and smoke drugs. Int J Drug Policy. 2013;24:156\u201363.","journal-title":"Int J Drug Policy"},{"key":"139_CR54","doi-asserted-by":"publisher","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","volume":"65","author":"RM Gladden","year":"2016","unstructured":"Gladden RM, Martinez P, Seth P. Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths\u201427 States, 2013\u20132014. MMWR Morb Mortal Wkly Rep. 2016;65:837\u201343.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"139_CR55","doi-asserted-by":"publisher","first-page":"844","DOI":"10.15585\/mmwr.mm6533a3","volume":"65","author":"AB Peterson","year":"2016","unstructured":"Peterson AB, Gladden RM, Delcher C, Spies E, Garcia-Williams A, Wang Y, Halpin J, Zibbell J, McCarty CL, DeFiore-Hyrmer J, DiOrio M, Goldberger BA. Increases in fentanyl-related overdose deaths\u2014Florida and Ohio, 2013\u20132015. MMWR Morb Mortal Wkly Rep. 2016;65:844\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"139_CR56","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.annemergmed.2014.07.017","volume":"64","author":"JM Stogner","year":"2014","unstructured":"Stogner JM. The potential threat of acetyl fentanyl: legal issues, contaminated heroin, and acetyl fentanyl \u201cdisguised\u201d as other opioids. Ann Emerg Med. 2014;64:637\u20139.","journal-title":"Ann Emerg Med"},{"key":"139_CR57","unstructured":"Increases in fentanyl drug confiscations and fentanyl-related overdose fatalities. CDC Health Alert Network, Centers for Disease Control and Prevention; 2015. \n                    https:\/\/emergency.cdc.gov\/han\/han00384.asp\n                    \n                  . Accessed 29 Oct 2016."},{"key":"139_CR58","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2105\/AJPH.2007.126284","volume":"98","author":"LD Moore","year":"2008","unstructured":"Moore LD, Elkavich A. Who\u2019s using and who\u2019s doing time: incarceration, the war on drugs, and public health. Am J Public Health. 2008;98:782\u20136.","journal-title":"Am J Public Health"},{"key":"139_CR59","unstructured":"Green, T, Rich, JD. Science needed for fentanyl crisis. The Huffington Post; 2016. \n                    http:\/\/www.huffingtonpost.com\/entry\/science-needed-for-fentanyl-crisis_us_575a924be4b053e21978bcd2\n                    \n                  ."},{"key":"139_CR60","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2105\/AJPH.2006.103747","volume":"98","author":"L Beletsky","year":"2008","unstructured":"Beletsky L, Davis CS, Anderson E, Burris S. The law (and politics) of safe injection facilities in the United States. Am J Public Health. 2008;98:231\u20137.","journal-title":"Am J Public Health"},{"key":"139_CR61","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.drugalcdep.2011.03.006","volume":"118","author":"S Semaan","year":"2011","unstructured":"Semaan S, Fleming P, Worrell C, Stolp H, Baack B, Miller M. Potential role of safer injection facilities in reducing HIV and Hepatitis C infections and overdose mortality in the United States. Drug Alcohol Depend. 2011;118:100\u201310.","journal-title":"Drug Alcohol Depend"},{"key":"139_CR62","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2105\/AJPH.2016.303523","volume":"107","author":"MC Kennedy","year":"2017","unstructured":"Kennedy MC, Kerr T. Overdose prevention in the United States: a call for supervised injection sites. Am J Public Health. 2017;107:42\u20133.","journal-title":"Am J Public Health"},{"key":"139_CR63","unstructured":"Foderaro LW. Ithaca\u2019s Anti-Heroin Plan: Open a Site to Shoot Heroin. The New York Times; 2016. \n                    http:\/\/www.nytimes.com\/2016\/03\/23\/nyregion\/fighting-heroin-ithaca-looks-to-injection-centers.html\n                    \n                  ."},{"key":"139_CR64","unstructured":"Noon A. A lawmaker wants to allow California addicts to use heroin, crack and other drugs at supervised facilities to cut down on overdoses. US News; 2016. \n                    http:\/\/www.usnews.com\/news\/us\/articles\/2016-04-05\/california-lawmaker-wants-to-allow-supervised-heroin-use\n                    \n                  ."},{"key":"139_CR65","unstructured":"Rector K. Two Baltimore-area lawmakers propose decriminalizing small amounts of all drugs, safe injection facilities. The Baltimore Sun; 2016. \n                    http:\/\/www.baltimoresun.com\/news\/maryland\/politics\/bs-md-morhaim-drug-bills-20160205-story.html\n                    \n                  ."},{"key":"139_CR66","unstructured":"Coleman V. Open \u2018safe places\u2019 in Seattle, King County for heroin use, task force says. The Seattle Times; 2016. \n                    http:\/\/www.seattletimes.com\/seattle-news\/crime\/open-public-sites-in-seattle-king-county-for-heroin-use-task-force-says\/\n                    \n                  ."},{"key":"139_CR67","unstructured":"Bebinger M. Boston Nonprofit Plans To Open A Room For Supervised Heroin Highs. Common Health. WBUR; 2015. \n                    http:\/\/www.wbur.org\/commonhealth\/2015\/11\/03\/heroin-safe-spaces\n                    \n                  ."},{"key":"139_CR68","unstructured":"Goldberg D, Pazmino G. Council, de Blasio administration to study supervised injection facilities. Politico New York. Politico; 2016. \n                    http:\/\/www.politico.com\/states\/new-york\/albany\/story\/2016\/09\/council-de-blasio-administration-to-study-supervised-injection-facilities-105869\n                    \n                  ."},{"key":"139_CR69","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1477-7517-11-28","volume":"11","author":"ME Smith","year":"2014","unstructured":"Smith ME, Robinowitz N, Chaulk P, Johnson KE. Self-care and risk reduction habits in older injection drug users with chronic wounds: a cross-sectional study. Harm Reduction J. 2014;11:28.","journal-title":"Harm Reduction J"},{"key":"139_CR70","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3109\/10826084.2010.517714","volume":"46","author":"W Small","year":"2011","unstructured":"Small W, Ainsworth L, Wood E, Kerr T. IDU Perspectives on the design and operation of North America\u2019s first medically supervised injection facility. Subst Use Misuse. 2011;46:561\u20138.","journal-title":"Subst Use Misuse"},{"key":"139_CR71","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/00952990.2011.600389","volume":"38","author":"K DeBeck","year":"2012","unstructured":"DeBeck K, Kerr T, Lai C, Buxton J, Montaner J, Wood E. The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs. Am J Drug Alcohol Abuse. 2012;38:55\u201362.","journal-title":"Am J Drug Alcohol Abuse"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-017-0139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12954-017-0139-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-017-0139-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T11:03:38Z","timestamp":1589540618000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-017-0139-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,20]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["139"],"URL":"https:\/\/doi.org\/10.1186\/s12954-017-0139-0","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,20]]},"assertion":[{"value":"30 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"13"}}